Last reviewed · How we verify
ALLO-ASC-TI
At a glance
| Generic name | ALLO-ASC-TI |
|---|---|
| Also known as | Allogenic adipose-derived stem cell |
| Sponsor | Anterogen Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |